ACMR · ACM Research, Inc.

Current Thesis

ACM Research's order-conversion recovery thesis has failed its published price test: the September 18, 2026 weekly close of $68.51 breached the $70 invalidation condition, while the next quarterly results remain the test of the operating story. The September 6 assessment that the breakdown had stopped extending is no longer supported by the adjusted closing-price record.

The investment narrative links China semiconductor-equipment localization to orders converting into revenue. Chief Executive David Wang reported first-half 2026 new-order growth of 105% on the August 7 earnings call. That operating claim remains distinct from the failed price structure: the narrative is dead in its previously published recovery form — the September 18 weekly close crossed the stated thesis-break level. This classification concerns the published market thesis, not a finding that the company's business has failed.

Bullish and bearish views on ACM Research, Inc.

The model's bull view on ACM Research, Inc. (ACMR), in brief: Orders support the operating argument. Wang's August 7, 2026 call reported first-half new orders rising 105% year over year, following the 65% growth reported at the May 7 call. These management disclosures support demand growth; they do not establish subsequent revenue… The bear view: The published condition has fired. The September 18, 2026 adjusted weekly close of $68.51 was below the $70 threshold published September 6. Treating that threshold as an unresolved future risk would misstate the record. Growth carries lower gross margins. Second-quarter 2026… Both cases follow in full.

Bull Case

• Orders support the operating argument. Wang's August 7, 2026 call reported first-half new orders rising 105% year over year, following the 65% growth reported at the May 7 call. These management disclosures support demand growth; they do not establish subsequent revenue recognition.
• Revenue guidance still supports expansion. On August 7, 2026, ACM reported second-quarter revenue of $292.9 million, up 36% year over year, and raised fiscal 2026 revenue guidance to $1.125–$1.175 billion. The operating expansion case would fail if subsequent guidance fell below that published lower bound. Company results.

Bear Case

• The published condition has fired. The September 18, 2026 adjusted weekly close of $68.51 was below the $70 threshold published September 6. Treating that threshold as an unresolved future risk would misstate the record.
• Growth carries lower gross margins. Second-quarter 2026 gross margin excluding stock-based compensation was 46.0%, against 48.7% a year earlier, according to the August 7 release. Revenue growth therefore did not preserve the prior-year margin. Company results.
• Issuance authorization remains a separate risk. The May 26, 2026 announcement authorized an ACM Shanghai Hong Kong offering without a fixed pricing date. Authorization is evidence of potential supply; it does not establish that an offering has occurred.

Setup & Price Structure

The September 18, 2026 adjusted close was $68.51, with a three-month price decline of 33.6% and a 46.0% distance below the recorded 52-week high. The 14-day relative strength index (RSI) was 40.2. These are measured price statistics, not evidence that a base has formed.

The $76.29 June base-low close identified in the September 6 dossier remains above the latest close. A weekly recovery above that historical shelf would contradict the assessment that the old base remains broken; it would not erase the intervening breach of $70. No lower support level is established by the supplied closing-price observations.

The September 4 analyst snapshot recorded nine covering analysts and an average published target of $117.75, following Daiwa's $136 initiation reported August 26. Those are historical coverage observations, not verified September 20 estimates or measurements of ownership. The September 17 retrospective investment-return headline supplies one example of retail-facing coverage; the sample is too small to support a crowding claim. Current moving-average distances, short interest and insider transaction data are missing.

Catalyst Calendar (next 30 days)

• September 20–October 20, 2026: ACM's investor-events page lists no upcoming events as checked September 20. No company-confirmed catalyst is established inside this window; an unscheduled announcement remains possible. Company calendar.
• ~November 10, 2026, estimated: The previously published provisional date for third-quarter results remains unconfirmed by the company. This later event matters because updated revenue guidance and gross margin would test the order-conversion argument; it is not a scheduled event within the next 30 days.

What Would Change Our Mind

The loss of the published recovery threshold is already observable: a weekly close below $70 occurred on September 18, 2026 at $68.51. The invalidation level remains unchanged for the public record.

A new recovery argument would require a weekly close above the historical $76.29 June shelf alongside operating confirmation. Retention of the August 7 fiscal 2026 revenue floor of $1.125 billion and third-quarter gross margin within management's stated 42–48% range would support that argument. A revenue-guidance reduction below that floor or gross margin below 42% would contradict it. These are conditions for reassessment, not evidence that recovery has begun.

Correlation Notes

This remains a single-name assessment. The September 18 price observations contain no matched peer-return series, so they cannot establish correlation with semiconductor equipment or artificial-intelligence infrastructure shares.

The August 7 company release identifies product mix, currency and customer spending as operating sensitivities. Those exposures explain why industry conditions matter, but do not demonstrate that a group rally would repair ACMR's breached structure. Company results.